Abstract Patients with Acute Myeloid Leukemia (AML) have compromised marrow function
and chemotherapy causes further suppression. As a result complications are frequent, and …

Patients receiving treatment for acute myeloid leukemia (AML) commonly experience life-
threatening complications requiring intensive care unit (ICU) support. This is a retrospective …

BACKGROUND. Predictors of outcome and rates of successful discharge have not been
defined for patients with acute leukemia admitted to intensive care units (ICUs) in the US …

Abstract Changes in acute myeloid leukaemia (AML) treatment may affect requirement for
admission to and treatments in intensive care units (ICUs). We evaluated trends in ICU …

Background There is limited epidemiologic data on patients with acute myelogenous
(myeloid) leukemia (AML) requiring life-sustaining therapies in the intensive care unit (ICU) …

Background This retrospective, multicenter study aimed to reveal risk predictors for mortality
in the intensive care unit (ICU) as well as survival after ICU discharge in patients with acute …

Induction chemotherapy in AML patients may have life-threatening side effects requiring
intensive care unit (ICU) treatment. We analyzed all AML patients receiving intensive …

Patients with high-risk acute myeloid leukemia (AML) often experience intensive medical
care at the end of life (EOL), including high rates of hospitalizations and intensive care unit …

Aim. Remission induction can be associate, with the life threatening complications and
transfer to ICU of de novo acute myeloid leukemia (AML) patients (pts). We evaluate …

Identifying risk factors for intensive care unit (ICU) admission in acute leukemia (AL) patients
may guide decision-making and improve prognosis. We included all adult AL patients …